A segment of Covid-19 survivors face possible long-term complications
The post A segment of Covid-19 survivors face possible long-term complications appeared first on Pharmaceutical Technology.
View ArticleIsrael assesses myocarditis cases linked to Pfizer-BioNTech Covid-19 vaccine
The post Israel assesses myocarditis cases linked to Pfizer-BioNTech Covid-19 vaccine appeared first on Pharmaceutical Technology.
View ArticlePharmaEssentia resubmits BLA for polycythemia vera therapeutic
The post PharmaEssentia resubmits BLA for polycythemia vera therapeutic appeared first on Pharmaceutical Technology.
View ArticleExercise should be first line of defence against elevated blood pressure
The post Exercise should be first line of defence against elevated blood pressure appeared first on Pharmaceutical Technology.
View ArticleHypertension: study suggests ARBs should be used before ACE inhibitors
The post Hypertension: study suggests ARBs should be used before ACE inhibitors appeared first on Pharmaceutical Technology.
View ArticleFDA grants approval to Boehringer-Lilly’s Jardiance to treat HFrEF
The post FDA grants approval to Boehringer-Lilly’s Jardiance to treat HFrEF appeared first on Pharmaceutical Technology.
View ArticleFirst successful trial in heart failure with preserved ejection fraction
The post First successful trial in heart failure with preserved ejection fraction appeared first on Pharmaceutical Technology.
View ArticleMerck agrees to acquire Acceleron Pharma for $11.5bn
The post Merck agrees to acquire Acceleron Pharma for $11.5bn appeared first on Pharmaceutical Technology.
View ArticleAsia-Pacific has seen the largest growth in cardiovascular trials over the...
The post Asia-Pacific has seen the largest growth in cardiovascular trials over the past decade appeared first on Pharmaceutical Technology.
View ArticleFDA grants priority review to Boehringer-Lilly’s Jardiance for heart failure
The post FDA grants priority review to Boehringer-Lilly’s Jardiance for heart failure appeared first on Pharmaceutical Technology.
View Article